CH658389A5 - Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. - Google Patents
Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. Download PDFInfo
- Publication number
- CH658389A5 CH658389A5 CH925/84A CH92584A CH658389A5 CH 658389 A5 CH658389 A5 CH 658389A5 CH 925/84 A CH925/84 A CH 925/84A CH 92584 A CH92584 A CH 92584A CH 658389 A5 CH658389 A5 CH 658389A5
- Authority
- CH
- Switzerland
- Prior art keywords
- prophylaxis
- diltiazem
- treatment
- arteriosclerosis
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58031515A JPS59157021A (ja) | 1983-02-25 | 1983-02-25 | 動脈硬化症予防治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH658389A5 true CH658389A5 (de) | 1986-11-14 |
Family
ID=12333337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH925/84A CH658389A5 (de) | 1983-02-25 | 1984-02-24 | Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS59157021A (ko) |
| BE (1) | BE899000A (ko) |
| CH (1) | CH658389A5 (ko) |
| DE (1) | DE3406837A1 (ko) |
| DK (1) | DK163712C (ko) |
| FR (1) | FR2541577B1 (ko) |
| GB (1) | GB2135192B (ko) |
| HK (1) | HK45389A (ko) |
| IT (1) | IT1178863B (ko) |
| NL (1) | NL8400548A (ko) |
| SE (1) | SE8400971L (ko) |
| SG (1) | SG21189G (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778791A (en) * | 1986-05-16 | 1988-10-18 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical composition for improving constitution of lipids in blood |
| JPS63107925A (ja) * | 1986-05-23 | 1988-05-12 | Tanabe Seiyaku Co Ltd | 動脈硬化症予防・治療剤 |
| JP2658783B2 (ja) * | 1992-12-10 | 1997-09-30 | 田辺製薬株式会社 | 抗動脈硬化剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3562257A (en) * | 1967-10-28 | 1971-02-09 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
| GB1236467A (en) * | 1967-10-28 | 1971-06-23 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
-
1983
- 1983-02-25 JP JP58031515A patent/JPS59157021A/ja active Granted
-
1984
- 1984-02-21 NL NL8400548A patent/NL8400548A/nl not_active Application Discontinuation
- 1984-02-22 SE SE8400971A patent/SE8400971L/ unknown
- 1984-02-24 DE DE19843406837 patent/DE3406837A1/de active Granted
- 1984-02-24 FR FR8402895A patent/FR2541577B1/fr not_active Expired
- 1984-02-24 CH CH925/84A patent/CH658389A5/de not_active IP Right Cessation
- 1984-02-24 BE BE0/212448A patent/BE899000A/fr not_active IP Right Cessation
- 1984-02-24 IT IT8467183A patent/IT1178863B/it active
- 1984-02-24 DK DK103084A patent/DK163712C/da not_active IP Right Cessation
- 1984-02-27 GB GB08405060A patent/GB2135192B/en not_active Expired
-
1989
- 1989-04-07 SG SG211/89A patent/SG21189G/en unknown
- 1989-06-07 HK HK453/89A patent/HK45389A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK103084A (da) | 1984-08-26 |
| JPS59157021A (ja) | 1984-09-06 |
| GB2135192B (en) | 1986-10-22 |
| IT1178863B (it) | 1987-09-16 |
| JPS6358809B2 (ko) | 1988-11-17 |
| GB8405060D0 (en) | 1984-04-04 |
| DE3406837A1 (de) | 1984-08-30 |
| BE899000A (fr) | 1984-06-18 |
| IT8467183A1 (it) | 1985-08-24 |
| FR2541577A1 (fr) | 1984-08-31 |
| GB2135192A (en) | 1984-08-30 |
| SE8400971L (sv) | 1984-08-26 |
| DK163712B (da) | 1992-03-30 |
| SG21189G (en) | 1990-01-26 |
| SE8400971D0 (sv) | 1984-02-22 |
| DE3406837C2 (ko) | 1990-12-20 |
| HK45389A (en) | 1989-06-16 |
| IT8467183A0 (it) | 1984-02-24 |
| NL8400548A (nl) | 1984-09-17 |
| DK103084D0 (da) | 1984-02-24 |
| DK163712C (da) | 1992-08-31 |
| FR2541577B1 (fr) | 1987-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH644267A5 (en) | Pharmaceutical compositions containing (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides | |
| DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
| AT389998B (de) | Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung | |
| DE3390114T1 (de) | Verbesserte analgetische und antiinflammatorische, Ibuprofen enthaltende Zubereitungen und Verfahren zu ihrer Herstellung | |
| EP0214620A2 (de) | Transdermale Applikationsform von Diltiazem | |
| DE2921852A1 (de) | Lipide senkendes mittel | |
| DE69006707T2 (de) | Verwendung von Fluorochinolon-Derivaten zur Behandlung der Pneumocystis carinii Pneumonie. | |
| DE2514335C3 (de) | Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung | |
| EP0224810B1 (de) | Antihypertensives Kombinationspräparat | |
| DE3643119A1 (de) | Therapeutische zusammensetzung fuer diabetes-komplikationen | |
| DE60206280T2 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
| CH660556A5 (de) | Therapeutische zubereitung zur behandlung von kardiovaskulaeren krankheiten. | |
| DE69308762T2 (de) | Behandlung des Muskulschwunds | |
| CH658389A5 (de) | Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. | |
| DE2335216A1 (de) | Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung | |
| DE1900772C3 (de) | Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel | |
| EP0207193A2 (de) | Synergistische Kombination von Flupirtin und 4-Acetamido-phenol | |
| DE69004529T2 (de) | Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen. | |
| EP0557876B1 (de) | Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation | |
| DE3419425C2 (ko) | ||
| DE2528460A1 (de) | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans | |
| EP0979083B1 (de) | Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen | |
| DE3781456T2 (de) | Pharmazeutische zusammensetzung, die eine 8-chlor-benzothiazepin-verbindung enthaelt und ihre verwendung. | |
| DE60109799T2 (de) | Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen | |
| DE3410850A1 (de) | Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |